isradipine has been researched along with indocyanine green in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cotting, J; Kutz, K; Laplanche, R; Nüesch, E; Reichen, J | 1 |
| Klockowski, PM; Lener, ME; Rocci, ML; Sirgo, MA | 1 |
1 review(s) available for isradipine and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for isradipine and indocyanine green
| Article | Year |
|---|---|
Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearances in elderly volunteers.
Topics: Aged; Aged, 80 and over; Antipyrine; Biomarkers; Calcium Channel Blockers; Diltiazem; Humans; Indocyanine Green; Isradipine; Liver; Liver Circulation; Oxidation-Reduction; Pyridines | 1990 |
3 other study(ies) available for isradipine and indocyanine green
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Pharmacokinetics of isradipine in patients with chronic liver disease.
Topics: Administration, Oral; Adult; Aminopyrine; Bile Acids and Salts; Biotransformation; Chronic Disease; Hepatitis; Humans; Indocyanine Green; Injections, Intravenous; Isradipine; Liver Diseases; Liver Function Tests; Male; Middle Aged; Models, Biological; Pyridines | 1990 |